Providing medical services, namely, gene therapy medical services in the field of genetic diseases and disorders; providing medical services, namely, gene therapy medical services in the field of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, fungal and viral diseases and disorders; dispensing of pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction

Class [001]
Chemical Products

Chemical and biochemical products for use in gene delivery technology, namely, nucleic acids, coding and non-coding deoxyribonucleic acids, ribonucleic acids, plasmids, vectors, promotors, enhancers and other regulatory sequences, all for in-vivo laboratory use in gene therapy

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of genetic diseases and disorders; Pharmaceutical preparations for the treatment of liver, hepatological, cardiovascular, central nervous system, endocrine, gastrointestinal, immunological, dermatological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmologic, psychiatric, respiratory, urogenital, urological, hematologic, and fungal and viral diseases and disorders; pharmaceutical preparations for the treatment of cancer, pain, diabetes, damaged skin, damaged tissue and addiction; Gene therapy and prophylaxis products, namely, gene transfer, regulation, modulation and delivery pharmaceutical preparations for the treatment of genetic diseases and disorders

Class [042]
Computer & Software Services & Scientific Services

Biomedical and scientific research in the fields of genome editing, gene editing, genome engineering, gene modulation, genetic diseases, gene therapy, and cell therapy; product development in the fields of genetic therapies and effectors to regulate, modulate, and characterize disease states; pharmaceutical research and development in the field of gene therapy; conducting clinical trials for others in the field of gene therapy design and delivery; biomedical research in the field of gene therapy design and delivery; diagnostics services in the field of equipment used for gene therapy design and delivery; gene therapy design and delivery development of biochemical assays

Mark Details

Serial Number

No 87449309

Mark Type

No Service Mark

Attorney Docket Number

No DIM-600A

44D Filed

44D Current

44E filed

44E Current

66A Filed

66A Current

Current Basis

No Basis

Legal History

Status Date	Action Taken
10^th Dec 2018	ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
10^th Dec 2018	ABANDONMENT - NO USE STATEMENT FILED
08^th May 2018	NOA E-MAILED - SOU REQUIRED FROM APPLICANT
13^th Mar 2018	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13^th Mar 2018	PUBLISHED FOR OPPOSITION
21^st Feb 2018	NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07^th Feb 2018	EXAMINERS AMENDMENT -WRITTEN
07^th Feb 2018	EXAMINER'S AMENDMENT ENTERED
07^th Feb 2018	APPROVED FOR PUB - PRINCIPAL REGISTER
07^th Feb 2018	EXAMINERS AMENDMENT E-MAILED

DIMENSION THERAPEUTICS

Classification Information

Class [044]Medical, Beauty & Agricultural Services

Class [001]Chemical Products

Class [005]Pharmaceutical Products

Class [042]Computer & Software Services & Scientific Services